CannabisNewsBreaks

FridayApr 27, 2018 2:35 pm

CannabisNewsBreaks – Global Hemp Group, Inc. (CSE: GHG) (FRA: GHG) (OTC: GBHPF) Takes Aim at Non-Psychoactive Cannabis-based Consumer Goods Market

British Columbia-based hemp cultivation company Global Hemp Group (CSE: GHG) (FRANKFURT: GHG) (OTC: GBHPF) remains focused on developing its strategic portfolio. An article discussing the company reads: “As pending legislation authorizing the cultivation of hemp without drug enforcement oversight opens the potential for U.S. federal government friendliness toward cannabis production, Global Hemp Group, Inc. (CSE: GHG) (FRANKFURT: GHG) (OTC: GBHPF) is busy pledging its visionary portfolio to the market for consumer goods arising from the cannabis species’ non-psychoactive varieties. … Global Hemp Group joined other players in the delicate industrial hemp arena in praising Sen. Mitch McConnell’s long-time efforts to…

Continue Reading

FridayApr 27, 2018 11:47 am

CannabisNewsBreaks – The Green Organic Dutchman Holdings Ltd. Sets Date of IPO on the Toronto Stock Exchange

The Green Organic Dutchman Holdings Ltd., also known as TGOD, recently set the date of its initial public offering (“IPO”), as well as its first day of trading under the symbols “TGOD” and “TGOD.WT” on the Toronto Stock Exchange (“TSX”), for May 2, 2018. The company is a producer of farm grown, organic, pesticide-free medical cannabis that is licensed under the Access to Cannabis for Medical Purposes Regulations (“ACMPR”). By leveraging advanced technology and low-cost power solutions, TGOD is uniquely positioned as one of the highest quality and most cost-efficient cannabis producers in Canada. To learn more, visit www.tgod.ca. About…

Continue Reading

ThursdayApr 26, 2018 4:16 pm

CannabisNewsBreaks – Why TransCanna™ is “One to Watch”

TransCanna™ specializes in helping its clients, which are comprised of cannabis farmers and manufacturers, become recognized by end consumers who in turn purchase their products. An article discussing the company reads: “TransCanna™ has already entered into an Intellectual Property Rights and Royalty Agreement for the Track & Trace software platform required by the state of California and has received a transportation and distribution permit from the city of Adelanto. TransCanna™ has also executed a land lease to build a 10,000 square foot transportation and distribution facility in Adelanto. … TransCanna™ is strategically creating a distribution network throughout California that places…

Continue Reading

ThursdayApr 26, 2018 12:03 pm

CannabisNewsBreaks – Beleave Inc. (CSE: BE) (OTCQX: BLEVF) Announces Binding Commitments for $5M Private Placement

Cannabis-focused biotech company Beleave Inc. (CSE: BE) (OTCQX: BLEVF) this morning announced that, in reference to a previously detailed non-brokered private placement, it has received binding commitments for total proceeds of $5 million at a price of $1.75 per unit. Each unit is comprised of one common share of the company and one-half of one common share purchase warrant, valid for a period of 24 months from the date of issuance with an exercise price of $2.25, subject to certain accelerated expiry conditions. “The company is pleased to welcome a new group of investors, bolster the treasury and add to…

Continue Reading

WednesdayApr 25, 2018 9:23 am

CannabisNewsBreaks – Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Enters Definitive License Agreement with GP Holdings LLC.

Drug delivery platform innovator Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP) this morning announced that it has entered a definitive technology licensing agreement with California cannabis beverage manufacturer GP Holdings LLC. Per the agreement, the company will provide its patented DehydraTECH™ technology to enable next-generation performance in high absorption, fast acting cannabis infused beverages to be developed and sold in California. The agreement grants GP five-year semi-exclusive rights to use Lexaria's DehydraTECH™ technology for beverage applications within California for an undisclosed sum and a royalty on revenue generated on the products sold. In addition, GP has also acquired matching rights…

Continue Reading

TuesdayApr 24, 2018 2:48 pm

CannabisNewsBreaks – Choom Holdings Inc. (CSE: CHOO) (OTCQB: CHOOF) Bold Strategy Demonstrates Success through Retail Investor Program

British Columbia-based cannabis cultivation firm Choom Holdings Inc. (CSE: CHOO) (OTCQB: CHOOF) inked its first agreement in its retail investor program in March 2018. An article discussing the deal reads: “Following its bold agenda, Choom™ has inked a deal not for just a single store but rather for an entire territory. A consortium of local investors and business partners known as the ‘Thompson Okanagan Choom Group’ has secured the exclusive territory rights to open multiple Choom™ branded retail dispensaries in the Thompson-Okanagan region. The Thompson-Okanagan region is a tourist magnet located in the central interior of British Columbia and offers…

Continue Reading

MondayApr 23, 2018 12:21 pm

CannabisNewsBreaks – Pivot Pharmaceuticals Inc. (CSE: PVOT) (OTCQB: PVOTF) (FRA: NPAT) Holds Promising Position in Expanding Cannabis Space

With its proven pharmaceutical and patented formulation and delivery technologies, Vancouver-based biopharmaceutical company Pivot Pharmaceuticals Inc. (CSE: PVOT) (OTCQB: PVOTF) (FRA: NPAT) holds a favorable position in an expanding vertical of the cannabis industry. An article discussing the company reads: “Pivot Pharmaceuticals has assembled cutting-edge drug delivery technologies that assist both effectiveness and efficacy of medicinal cannabinoids and have potential applications across other drug categories. Pivot’s patent pending topical transdermal drug delivery technology platform, BiPhasix™, has been shown to significantly enhance the bioavailability of various drugs, leading to improved clinical outcomes. The company also acquired worldwide rights to Solmic Solubilisation…

Continue Reading

MondayApr 23, 2018 9:29 am

CannabisNewsBreaks – Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Initiates Human Clinical Study on TurboCBD Capsules; Presenting Breakthrough Nicotine Absorption Study Results

Drug delivery platform innovator Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP) this morning announced that it has commenced a clinical study in Europe that is evaluating the cardiovascular and cognitive health effects of Lexaria's high absorption TurboCBD™ capsules. The data produced by the study will be of significant benefit to the company and its partners, providing objective human performance findings that will support the development of Lexaria’s next-generation cannabinoid product formulations. Results of the study are anticipated within 90 days. In addition, Lexaria also announced that it will be presenting the results of its recent breakthrough nicotine absorption study at…

Continue Reading

FridayApr 20, 2018 2:48 pm

CannabisNewsBreaks – Global Hemp Group, Inc. (CSE: GHG) (FRA: GHG) (OTC: GBHPF) Anticipates Senate Bill Addressing Hemp Regulation

Hemp cultivation company Global Hemp Group (CSE: GHG) (FRANKFURT: GHG) (OTC: GBHPF) is set to profit from if the Hemp Farming Act of 2018 passes. The bill would bring hemp farming into the mainstream. An article discussing the company reads: “Global Hemp Group, Inc. (CSE: GHG) (FRANKFURT: GHG) (OTC: GBHPF) is joining other leaders in the hemp industry through its anticipation of the impending Senate bill, sponsored by Majority Leader Mitch McConnell, that would remove hemp from the scheduled list of controlled substances in the U.S. and, instead, make it an agricultural commodity (http://cnw.fm/GNQ7v). “It’s now time to take the…

Continue Reading

ThursdayApr 19, 2018 10:24 am

CannabisNewsBreaks – Hiku Brands Co. Ltd. (CSE: HIKU) (OTC: DJACF) and WeedMD, Inc. (TSX-V: WMD) (OTC: WDDMF) (FSE: 4WE) Enter Agreement to Merge

Canada’s first vertically-integrated cannabis brand house Hiku Brands Co. Ltd. (CSE: HIKU) (OTC: DJACF), along with WeedMD Inc. (TSX-V: WMD) (OTC: WDDMF) (FSE: 4WE), this morning announced that the companies have entered into a definitive agreement to merge the two companies. Upon completion of the transaction, existing Hiku and WeedMD shareholders will own roughly 51.75% and 48.25% of the combined company, respectively, on a fully-diluted basis. Common shares of the resulting entity are anticipated to be listed on the TSX Venture Exchange, subject to regulatory approvals. Hiku and WeedMD are hosting a conference call on Friday, April 20, 2018 beginning at 10…

Continue Reading